Sagility Limited (NSE:SAGILITY)
India · Delayed Price · Currency is INR 43.35
+0.71 (1.67%)
Aug 21, 2026, 3:30 PM IST
Sagility Revenue
Sagility had revenue of 19.63B INR in the quarter ending June 30, 2026, with 27.59% growth. This brings the company's revenue in the last twelve months to 76.17B, up 29.43% year-over-year. In the fiscal year ending March 31, 2026, Sagility had annual revenue of 71.93B with 29.14% growth.
Revenue (ttm)
76.17B
Revenue Growth
+29.43%
P/S Ratio
2.66
Revenue / Employee
1.63M
Employees
47,307
Market Cap
202.94B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 71.93B | 16.23B | 29.14% |
| Mar 31, 2025 | 55.70B | 8.16B | 17.17% |
| Mar 31, 2024 | 47.54B | 5.35B | 12.69% |
| Mar 31, 2023 | 42.18B | 28.33B | 204.55% |
| Mar 31, 2022 | 13.85B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Cipla | 280.68B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Alembic Pharmaceuticals | 77.84B |
| Eris Lifesciences | 32.12B |
| Alivus Life Sciences | 25.90B |
| Pfizer | 25.70B |
Sagility News
- 4 weeks ago - Sagility Transcript: Q1 26/27 - Transcripts
- 4 weeks ago - Sagility Quarterly report: Q1 2027 - Filings
- 4 weeks ago - Sagility Slides: Q1 2027 - Filings
- 3 months ago - Sagility Transcript: Q4 25/26 - Transcripts
- 3 months ago - Sagility Quarterly report: Q4 2026 - Filings
- 3 months ago - Sagility Slides: Q4 2026 - Filings
- 3 months ago - Sagility Annual report: Q4 2026 - Filings
- 5 months ago - Sagility Transcript: Investor Day 2026 - Transcripts